Latest Period
Q2 2026
Security Snapshot
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) Institutional Ownership
CUSIP: 000899104
13F Institutional Holders and Ownership History from Q2 2014 to Q2 2026
Institutions Reporting
318
Shares (Excl. Options)
202,608,760
Price
$8.37
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- ADMA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 202,608,760
- Total 13F value
- $1,696,204,693
- Portfolio coverage rank
- 0%
- Share change
- -8,172,116
- Value change
- -$73,125,972
- Number of holders
- 318
- Shares outstanding
- 231,297,595
- SEC-reported price per share
- $8.59
- Insider filing price
- $8.59
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK is tracked under CUSIP 000899104.
- 318 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 350 to 318 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,905,691,659 to $1,696,204,693.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 318 institutions filings for Q2 2026.
Security key
000899104
Latest holder period
Q2 2026
13F holders
318
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
ADMA full holder history
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
ADMA BIOLOGICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 000899104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
ADMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $865,732,260 | 35,907,601 | BlackRock, Inc. | 31 Mar 2025 | |||
| STATE STREET CORP | 7.4% | +46% | $143,261,104 | +$42,164,017 | 17,116,022 | +42% | STATE STREET CORPORATION | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $109,112,479 | 12,110,153 | Vanguard Capital Management | 31 Mar 2026 | |||
| Invesco Ltd. | 5% | -8% | $211,308,672 | -$19,394,917 | 11,785,202 | -8.4% | Invesco Ltd. | 31 Dec 2025 |
As of 30 Jun 2026, 318 institutional investors reported holding 202,608,760 shares of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA). This represents 88% of the company’s total 231,297,595 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
67%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 17% | 38,355,684 | +4.1% | 0% | $321,037,075 |
| STATE STREET CORP | 7.4% | 17,116,022 | +22% | 0% | $143,261,104 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 10,103,809 | -2% | 0% | $84,568,881 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.4% | 10,088,490 | +14% | 0% | $84,440,661 |
| Rubric Capital Management LP | 4% | 9,339,414 | +416% | 0.72% | $78,170,895 |
| Capital Research Global Investors | 3.8% | 8,756,374 | -22% | 0.01% | $73,290,850 |
| FIRST TRUST ADVISORS LP | 3.4% | 7,798,351 | +2065% | 0.04% | $65,272,197 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 6,059,984 | +4% | 0% | $50,731,358 |
| Caligan Partners LP | 2.5% | 5,725,007 | +20% | 2.3% | $47,918,309 |
| D. E. Shaw & Co., Inc. | 2.3% | 5,274,597 | +841% | 0.03% | $44,148,376 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 3,606,208 | -28% | 0.01% | $30,183,960 |
| GOLDMAN SACHS GROUP INC | 1.5% | 3,513,583 | +25% | 0% | $29,408,690 |
| B Group, Inc. | 1.4% | 3,262,542 | +1.7% | 15% | $27,307,477 |
| Nuveen, LLC | 1.4% | 3,260,349 | -47% | 0.01% | $27,289,121 |
| Duquesne Family Office LLC | 1.2% | 2,784,110 | +80% | 0.54% | $23,303,000 |
| NORTHERN TRUST CORP | 1% | 2,415,971 | +6.1% | 0% | $20,221,678 |
| Nantahala Capital Management, LLC | 1% | 2,359,993 | 1.2% | $19,753,141 | |
| MORGAN STANLEY | 0.98% | 2,265,443 | -6.9% | 0% | $18,961,760 |
| Ranger Investment Management, L.P. | 0.91% | 2,115,417 | -7.4% | 1.1% | $17,706,040 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.9% | 2,092,594 | -0.15% | 0% | $17,515,012 |
| TWO SIGMA INVESTMENTS, LP | 0.87% | 2,019,887 | -3.5% | 0.01% | $16,906,454 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.76% | 1,755,152 | +327% | 0.26% | $14,690,622 |
| VANGUARD FIDUCIARY TRUST CO | 0.72% | 1,654,613 | +1% | 0% | $13,849,111 |
| Fundsmith LLP | 0.71% | 1,649,493 | 0% | 0.1% | $13,806,256 |
| BANK OF AMERICA CORP /DE/ | 0.71% | 1,647,647 | -59% | 0% | $13,790,805 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q2 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 202,608,760 | $1,696,204,693 | -$73,125,972 | $8.37 | 318 |
| 2026 Q1 | 211,485,966 | $1,905,691,659 | -$344,965,778 | $9.01 | 350 |
| 2025 Q4 | 220,099,170 | $4,014,361,970 | +$38,654,995 | $18.24 | 353 |
| 2025 Q3 | 218,105,635 | $3,198,245,207 | +$72,502,856 | $14.66 | 359 |
| 2025 Q2 | 210,797,270 | $3,837,973,056 | +$78,904,738 | $18.21 | 367 |
| 2025 Q1 | 205,274,525 | $4,072,982,276 | +$76,450,592 | $19.84 | 342 |
| 2024 Q4 | 203,746,953 | $3,496,535,119 | -$114,107,061 | $17.15 | 316 |
| 2024 Q3 | 207,372,865 | $4,143,053,602 | +$165,315,203 | $19.99 | 300 |
| 2024 Q2 | 181,187,738 | $2,025,731,155 | +$84,927,207 | $11.18 | 251 |
| 2024 Q1 | 174,472,998 | $1,151,565,465 | +$38,336,177 | $6.60 | 213 |
| 2023 Q4 | 169,158,841 | $764,627,025 | -$2,944,733 | $4.52 | 184 |
| 2023 Q3 | 171,151,086 | $612,714,569 | +$20,026,265 | $3.58 | 188 |
| 2023 Q2 | 165,493,139 | $610,610,254 | +$2,418,775 | $3.69 | 178 |
| 2023 Q1 | 165,334,603 | $547,246,486 | +$39,069,063 | $3.31 | 161 |
| 2022 Q4 | 152,691,438 | $592,428,828 | +$84,016,367 | $3.88 | 160 |
| 2022 Q3 | 129,844,191 | $315,525,087 | +$25,706,332 | $2.43 | 126 |
| 2022 Q2 | 119,212,509 | $236,039,706 | +$28,768,170 | $1.98 | 106 |
| 2022 Q1 | 104,891,672 | $189,908,374 | +$15,200,552 | $1.83 | 101 |
| 2021 Q4 | 97,211,593 | $137,058,638 | +$69,617,810 | $1.41 | 79 |
| 2021 Q3 | 41,605,720 | $47,012,568 | -$1,898,278 | $1.13 | 65 |
| 2021 Q2 | 42,881,498 | $68,611,517 | -$9,321,193 | $1.60 | 77 |
| 2021 Q1 | 48,542,943 | $85,432,065 | +$4,580,090 | $1.76 | 99 |
| 2020 Q4 | 45,108,342 | $87,965,210 | -$3,255,262 | $1.95 | 88 |
| 2020 Q3 | 46,229,823 | $110,365,108 | -$6,638,253 | $2.39 | 89 |
| 2020 Q2 | 48,795,314 | $143,056,287 | +$1,125,669 | $2.93 | 95 |